These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18429804)

  • 1. Successful treatment of recalcitrant warts with topical squaric acid in immunosuppressed child.
    Huang W; Morrell D
    Pediatr Dermatol; 2008; 25(2):275-6. PubMed ID: 18429804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy of multiple recurring warts. II. Reassessment of the use of squaric acid dibutylester (SADBE) (author's transl)].
    Claudy AL; Roche H
    Ann Dermatol Venereol; 1981; 108(10):765-7. PubMed ID: 7305218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts.
    Lee AN; Mallory SB
    J Am Acad Dermatol; 1999 Oct; 41(4):595-9. PubMed ID: 10495383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of topical immunotherapy with squaric acid dibutylester for refractory common warts on the face and neck.
    Hama N; Hatamochi A; Hayashi S; Namikawa H; Sotome A; Hamasaki Y; Yamazaki S
    J Dermatol; 2009 Dec; 36(12):660-2. PubMed ID: 19958453
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of recalcitrant periungual warts with cimetidine in pediatrics.
    Chern E; Cheng YW
    J Dermatolog Treat; 2010 Sep; 21(5):314-6. PubMed ID: 19707927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature.
    Cha S; Johnston L; Natkunam Y; Brown J
    Transpl Infect Dis; 2005; 7(3-4):158-61. PubMed ID: 16390407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive trichloroacetic acid therapy enhances squaric acid response to verruca vulgaris.
    Silverberg JI; Silverberg NB
    J Drugs Dermatol; 2012 Oct; 11(10):1228-30. PubMed ID: 23134989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of disseminated facial verrucae with contact immunotherapy.
    Weisshaar E; Neumann HJ; Gollnick H
    Eur J Dermatol; 1998; 8(7):488-91. PubMed ID: 9854160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5% 5-Fluorouracil cream for treatment of verruca vulgaris in children.
    Gladsjo JA; Alió Sáenz AB; Bergman J; Kricorian G; Cunningham BB
    Pediatr Dermatol; 2009; 26(3):279-85. PubMed ID: 19706088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical immunotherapy in dermatology.
    Buckley DA; du Vivier AW
    Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the efficacy and safety of squaric acid therapy for treatment of recalcitrant warts in children.
    Pandey S; Wilmer EN; Morrell DS
    Pediatr Dermatol; 2015; 32(1):85-90. PubMed ID: 25040421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verruca vulgaris of tympanic membrane treated with topical immunotherapy.
    Shangkuan WC; Lin MY
    Am J Otolaryngol; 2014; 35(2):242-5. PubMed ID: 24321751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of multiple warts in a renal transplant recipient with decreased laser doses after application of a light absorbing dye.
    Faurschou A; Wulf HC
    Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):265-6. PubMed ID: 16948830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of squaric acid dibutyl ester in treatment of recalcitrant warts in children.
    Bagherani N
    Dermatol Ther; 2015; 28(5):330. PubMed ID: 25817990
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of verruca with DNCB].
    Intrator F; de Oliveira Borges AR; Assunção Filho CT; Sudo L
    Med Cutan Ibero Lat Am; 1985; 13(5):419-22. PubMed ID: 3914594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cantharidin treatment for recalcitrant facial flat warts: a preliminary study.
    Kartal Durmazlar SP; Atacan D; Eskioglu F
    J Dermatolog Treat; 2009; 20(2):114-9. PubMed ID: 18821118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of predominantly recalcitrant cutaneous warts to topical chemotherapy.
    Davis MD; Weick JA; Link JS
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):232-4. PubMed ID: 16441648
    [No Abstract]   [Full Text] [Related]  

  • 18. Squaric acid dibutylester: indications for use and efficacy in alopecia areata.
    Pardasani AG; Turner E; McMichael AJ
    Arch Dermatol; 2001 Jul; 137(7):970-2. PubMed ID: 11453831
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of squaric acid dibutylester (SADBE) for cutaneous warts in children.
    Micali G; Nasca MR; Tedeschi A; Dall'Oglio F; Pulvirenti N
    Pediatr Dermatol; 2000; 17(4):315-8. PubMed ID: 10990585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact immunotherapy with squaric acid dibutylester for warts [corrected].
    Iijima S; Otsuka F
    Dermatology; 1993; 187(2):115-8. PubMed ID: 8358098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.